共 7 条
[1]
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Farrington P,Pugh S,Colville A,et al. The Lancet . 1995
[3]
Immunogenicity/reactogenicity safety of3vaccine lots VS Merck&Co’s MMR vaccine in healthy children aged15to18months(OL). Lee CY. .
[4]
WHO Position on use of measles mumps and rubella (MMR)vaccine. PAHO. EPI Newsletter . 2001
[5]
Measles vaccine. Markowitz LE,Katz SL. Vaccines . 1994
[6]
预防接种手册[M]. 上海科学技术文献出版社 , 迮文远主编, 1997